News

No. Title Writer Date Inquiry
22 A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
관리자 23.05.19 Inquiry : 1,895
관리자 23.05.19 1,895
21 Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury
관리자 23.01.17 Inquiry : 2,084
관리자 23.01.17 2,084
20 3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
관리자 23.01.17 Inquiry : 1,864
관리자 23.01.17 1,864
19 Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
관리자 23.01.17 Inquiry : 1,978
관리자 23.01.17 1,978
18 Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).
관리자 23.01.17 Inquiry : 2,016
관리자 23.01.17 2,016
17 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, ACS P
관리자 23.01.17 Inquiry : 1,928
관리자 23.01.17 1,928
16 Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement(CRADA) with the National Institutes of Health(NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience(March 2)
관리자 23.01.17 Inquiry : 1,820
관리자 23.01.17 1,820
15 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, eLife
관리자 23.01.17 Inquiry : 1,849
관리자 23.01.17 1,849
14 The 6th Target Protein Dissolution Summit
관리자 23.06.22 Inquiry : 2,040
관리자 23.06.22 2,040
13 Patent license agreement with KRICT
관리자 23.05.19 Inquiry : 1,964
관리자 23.05.19 1,964